Trial
NCT03436953
A Phase 2 Study of CX-8998 in Adults With Tremor Associated With Parkinson's Disease
Phase IIWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Jazz Pharmaceuticals
Collaborators
—
Condition
Parkinson's Disease
Intervention
CX-8998
Why stopped
The program was not initiated nor were any patients ever enrolled. The investigations detailed in the submitted protocol were incorporated into another program.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-05-28